Grant Life Sciences

Grant Life Sciences, Inc. researches, develops, and sells protein-based screening tests and diagnostic tools for the screening, monitoring, and diagnosis of diseases focused on women's health, infectious diseases, and cancer. It has developed blood-based screening tests to screen women for cervical cancer and precancerous conditions, detecting the presence of certain antibodies that appear when cervical cancer or certain precancerous conditions are present in the body. The company also holds licenses to develop and sell diagnostic devices for detecting HIV-1, HIV-2, and dengue fever. It serves customers in the United States, Europe, and internationally. Grant Life Sciences, Inc. was formerly known as Grant Ventures Inc. and changed its name to Grant Life Sciences, Inc. in December 2002. The company was founded in 1983 and is headquartered in Salt Lake City, Utah.